These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 7127293

  • 1. Kinetics of N-(phosphonacetyl)-L-aspartate and pyrazofurin depletion of pyrimidine ribonucleotide and deoxyribonucleotide pools and their relationship to nucleic acid synthesis in intact and permeabilized cells.
    Moyer JD, Smith PA, Levy EJ, Handschumacher RE.
    Cancer Res; 1982 Nov; 42(11):4525-31. PubMed ID: 7127293
    [Abstract] [Full Text] [Related]

  • 2. Selective inhibition of pyrimidine synthesis and depletion of nucleotide pools by N-(phosphonacetyl)-L-aspartate.
    Moyer JD, Handschumacher RE.
    Cancer Res; 1979 Aug; 39(8):3089-94. PubMed ID: 455293
    [No Abstract] [Full Text] [Related]

  • 3. Effect of N-(phosphonacetyl)-L-aspartate on 5-azacytidine metabolism in P388 and L1210 cells.
    Grant S, Rauscher F, Jakubowski A, Cadman E.
    Cancer Res; 1981 Feb; 41(2):410-8. PubMed ID: 6160908
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mechanism of synergy between N-phosphonacetyl-L-aspartate and dipyridamole in a human ovarian carcinoma cell line.
    Chan TC, Howell SB.
    Cancer Res; 1985 Aug; 45(8):3598-604. PubMed ID: 4016741
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The mechanism of action of 3-deazauridine in tumor cells sensitive and resistant to arabinosylcytosine.
    Brockman RW, Shaddix SC, Williams M, Nelson JA, Rose LM, Schabel FM.
    Ann N Y Acad Sci; 1975 Aug 08; 255():501-21. PubMed ID: 171997
    [Abstract] [Full Text] [Related]

  • 11. Mechanism of resistance of variants of the Lewis lung carcinoma to N-(phosphonacetyl)-L-aspartic acid.
    Kensler TW, Mutter G, Hankerson JG, Reck LJ, Harley C, Han N, Ardalan B, Cysyk RL, Johnson RK, Jayaram HN, Cooney DA.
    Cancer Res; 1981 Mar 08; 41(3):894-904. PubMed ID: 7459875
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Unexpected synergy between N-phosphonacetyl-L-aspartate and cytidine against human tumor cells.
    Chan TC, Howell SB.
    Eur J Cancer Clin Oncol; 1989 Apr 08; 25(4):721-7. PubMed ID: 2714348
    [Abstract] [Full Text] [Related]

  • 15. Effect of inhibitors of the de novo pyrimidine biosynthetic pathway on serum uridine levels in mice.
    Karle JM, Anderson LW, Dietrick DD, Cysyk RL.
    Cancer Res; 1981 Dec 08; 41(12 Pt 1):4952-5. PubMed ID: 6171344
    [Abstract] [Full Text] [Related]

  • 16. PALA enhancement of bromodeoxyuridine incorporation into DNA increases radiation cytotoxicity to human ovarian adenocarcinoma cells.
    Yang JL, Fernandes DJ, Wheeler KT, Capizzi RL.
    Int J Radiat Oncol Biol Phys; 1996 Mar 15; 34(5):1073-9. PubMed ID: 8600090
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Collateral sensitivity to N-(phosphonacetyl)-L-aspartic acid in a line of P388 leukemia cells selected for resistance to L-(alpha S, 5S)-alpha-amino-3- chloro-4,5-dihydro-5-isoxazoleacetic acid (acivicin).
    Ardalan B, Jayaram HN, Johnson RK.
    Cancer Res; 1983 Apr 15; 43(4):1598-601. PubMed ID: 6831405
    [Abstract] [Full Text] [Related]

  • 19. Differential effect of N-(phosphonacetyl)-L-aspartate on 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity in human leukemia and normal bone marrow progenitors.
    Grant S, Rauscher F, Cadman E.
    Cancer Res; 1982 Oct 15; 42(10):4007-13. PubMed ID: 6955007
    [Abstract] [Full Text] [Related]

  • 20. N-(phosphonacetyl)-L-aspartate synergistically enhances the cytotoxicity of 5-fluorouracil/interferon-alpha-2a against human colon cancer cell lines.
    Wadler S, Mao X, Bajaj R, Hallam S, Schwartz EL.
    Mol Pharmacol; 1993 Nov 15; 44(5):1070-6. PubMed ID: 8246910
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.